J&J COURT CASE FOR CONFIDE OWNERSHIP ARGUES THAT ARBITRATOR'S AWARD IS EXCESSIVE; ARBITRATION DECISION GIVES HOME HIV TEST ASSETS TO MILLENSON
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson's Direct Access Diagnostics business should take "extraordinary precautions" to preserve the assets of its Confide home HIV testing service until litigation over ownership of the assets is resolved, attorneys for former DAD President and CEO Elliot Millenson say in a July 26 letter to J&J.
You may also be interested in...
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.